The Spatial Effect of Fearful Faces in the Autonomic Response
Overview
Affiliations
Peripersonal space (PPS) corresponds to the space around the body and it is defined by the location in space where multimodal inputs from bodily and external stimuli are integrated. Its extent varies according to the characteristics of external stimuli, e.g., the salience of an emotional facial expression. In the present study, we investigated the psycho-physiological correlates of the extension phenomenon. Specifically, we investigated whether an approaching human face showing either an emotionally negative (fearful) or positive (joyful) facial expression would differentially modulate PPS representation, compared to the same face with a neutral expression. To this aim, we continuously recorded the skin conductance response (SCR) of 27 healthy participants while they watched approaching 3D avatar faces showing fearful, joyful or neutral expressions, and then pressed a button to respond to tactile stimuli delivered on their cheeks at three possible delays (visuo-tactile trials). The results revealed that the SCR to fearful faces, but not joyful or neutral faces, was modulated by the apparent distance from the participant's body. SCR increased from very far space to far and then to near space. We propose that the proximity of the fearful face provided a cue to the presence of a threat in the environment and elicited a robust and urgent organization of defensive responses. In contrast, there would be no need to organize defensive responses to joyful or neutral faces and, as a consequence, no SCR differences were found across spatial positions. These results confirm the defensive function of PPS.
Veranic K, Ewing L, Sambrook T, Watson E, Zhao M, Bayliss A Soc Cogn Affect Neurosci. 2025; 20(1).
PMID: 39825867 PMC: 11833688. DOI: 10.1093/scan/nsaf008.
"Sentio ergo est": Unmasking the psychological realities of emotional misperception.
Tsikandilakis M, Bali P, Karlis A, Morfi P, Mevel P, Madan C Perception. 2024; 54(1):3-31.
PMID: 39648752 PMC: 11646357. DOI: 10.1177/03010066241302996.
A Decade of Dedication: Pioneering Perspectives on Neurological Diseases and Mental Illnesses.
Tanaka M, Vecsei L Biomedicines. 2024; 12(5).
PMID: 38791045 PMC: 11117868. DOI: 10.3390/biomedicines12051083.
Are steroid hormones and autistic traits affected by metformin? First insights from a pilot.
Gasser B, Escher G, Calin A, Deppeler M, Marchon M, Kurz J Compr Psychoneuroendocrinol. 2023; 16:100196.
PMID: 37577184 PMC: 10415721. DOI: 10.1016/j.cpnec.2023.100196.
mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder.
Thomas S, Jha N, Ojha S, Sadek B Molecules. 2023; 28(4).
PMID: 36838876 PMC: 9964164. DOI: 10.3390/molecules28041889.